Time to capture post-pandemic growth in healthcare

IN 2019, the possibility that a large chunk of the population outside of the medical industry would understand what an mRNA vaccine is, would have seemed a little far-fetched. And yet, now in the second half of 2021, many ordinary people have become acquainted with some of the more complex issues around vaccine technology - such is the effect that the pandemic has had on our relationship with healthcare.

The events of the last 18 months have accelerated and shaped a number of trends in healthcare technology and services, to a point that even if the long awaited "return to normal" comes, many of these changes will remain around for the long term. The ageing populations of advanced economies across Japan, China, Europe and even here at home in Singapore, combined with an ever-increasing focus on individual wellness, will create a strong demand for new and innovative approaches to healthcare.

Just take a look at the growth of share prices of vaccine creators Pfizer and Moderna to date. These companies are now reaping the benefits by building on decades of research and development they have invested in, and are delivering important vaccines to save countless lives at this crucial moment. There are companies working on advancements right now that, in the not-too-distant future, will parallel the importance of Covid-19 vaccines.